Speaking of controversial issues others tend to avoid, we discuss our feeling on these new drugs that are very dangerous, and the FDA which is "fast track" approving these drugs...and why!

***REXULTI (brexpiprazole)
· Cerebrovascular Disease
·Neuroleptic Malignant Syndrome
·Tardive Dyskinesia
·Hyperglycemia
·LDL and HDL Cholesterol and Triglycerides
·Low white blood cell count or Neutropenia
·Orthostatic Hypotension
·What Is Dysphagia
·Rexulti Safety Info
·Drug Trials Snapshots: REXULTI
·FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
·Rexulti Interactions Checker
·British Medical Journal/Robert Whitaker-How the FDA approved an antipsychotic that failed to show a meaningful benefit but raised the risk of death
·Alzheimer’s Journal regarding Rexulti clinical trials
·FDA Briefing Document on Rexulti

*** CBD
·Current Clinical Trial Cannabidiol Oil for Agitation
·Cannabinoids for Agitation in Alzheimer's Disease
·Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's
·Caring for behavioral symptoms of dementia
·Sue Feldmeth, RN MC
·Rodger That: Using Cannabis to Treat Dementia :: Sue Feldmeth

*** LEQEMBI
·Leqembi Safety Information
·Alzheimer's Disease & Dementia Help

·Box Warning
·How serious is a box warning

Find Clinical Trials

To follow us on Twitter - @bobbicarducci2 -and- @michaelcarducc4

Click here to follow the Dementia Spotlight Facebook Page

(c) 2023-2025 Carducci Caregiving Consulting